Antag Therapeutics (Series A)
Funding Details
- Date Award
- June 08, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $84,300,000
Company Info
- Founding Year
- 2015
- Traction
- Raised $84.3 million in Series A funding.
- Company Description
- Antag Therapeutics is developing peptide-based treatments for obesity and related metabolic disorders.
- Market
- Healthcare
- Location
- Copenhagen, Denmark
- Coinvestors
- Novo Holdings, SR One, Dawn Biopharma, Pictet, Longview Ventures, Export & Investment Fund of Denmark